Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo

被引:66
作者
Brenchley, Jason M.
Ruff, Laura E.
Casazza, Joseph P.
Koup, Richard A.
Price, David A.
Douek, Daniel C.
机构
[1] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
D O I
10.1128/JVI.00070-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD4(+) T-cell help is essential for effective immune responses to viruses. In human immunodeficiency virus (HIV) infection, CD4(+) T cells specific for HIV are infected by the virus at higher frequencies than other memory CD4(+) T cells. Here, we demonstrate that HIV-specific CD4(+) T cells are barely detectable in most infected individuals and that the corresponding CD4(+) T cells exhibit an immature phenotype compared to both cytomegalovirus (CMV)-specific CD4(+) T cells and other memory CD4(+) T cells. However, in two individuals, we observed a rare and diametrically opposed pattern in which HIV-specific CD4(+) T-cell populations of large magnitude exhibited a terminally differentiated immunophenotype; these cells were not preferentially infected in vivo. Clonotypic analysis revealed that the HIV-specific CD4(+) T cells from these individuals were cross-reactive with CMV. Thus, preferential infection can be circumvented in the presence of cross-reactive CD4(+) T cells driven to maturity by coinfecting viral antigens, and this physical proximity rather than activation status per se is an important determinant of preferential infection based on antigen specificity. These data demonstrate that preferential infection reduces the life span of HIV-specific CD4(+) T cells in vivo and thereby compromises the generation of effective immune responses to the virus itself; further, this central feature in the pathophysiology of HIV infection can be influenced by the cross-reactivity of responding CD4(+) T cells.
引用
收藏
页码:6801 / 6809
页数:9
相关论文
共 45 条
  • [1] Putative immunodominant human immunodeficiency virus-specific CD8+ T-Cell responses cannot be predicted by major histocompatibility complex class I haplotype
    Betts, MR
    Casazza, JP
    Patterson, BA
    Waldrop, S
    Trigona, W
    Fu, TM
    Kern, F
    Picker, LJ
    Koup, RA
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (19) : 9144 - 9151
  • [2] Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection
    Betts, MR
    Ambrozak, DR
    Douek, DC
    Bonhoeffer, S
    Brenchley, JM
    Casazza, JP
    Koup, RA
    Picker, LJ
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (24) : 11983 - 11991
  • [3] An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC)
    Birch, MR
    Learmont, JC
    Dyer, WB
    Deacon, NJ
    Zaunders, JJ
    Saksena, N
    Cunningham, AL
    Mills, J
    Sullivan, JS
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (03) : 263 - 270
  • [4] Presence of HIV-1 gag-specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection
    Boaz, MJ
    Waters, A
    Murad, S
    Easterbrook, PJ
    Vyakarnam, A
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (11) : 6376 - 6385
  • [5] Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
    Brenchley, JM
    Karandikar, NJ
    Betts, MR
    Ambrozak, DR
    Hill, BJ
    Crotty, LE
    Casazza, JP
    Kuruppu, J
    Migueles, SA
    Connors, M
    Roederer, M
    Douek, DC
    Koup, RA
    [J]. BLOOD, 2003, 101 (07) : 2711 - 2720
  • [6] T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis
    Brenchley, JM
    Hill, BJ
    Ambrozak, DR
    Price, DA
    Guenaga, FJ
    Casazza, JP
    Kuruppu, J
    Yazdani, J
    Migueles, SA
    Connors, M
    Roederer, M
    Douek, DC
    Koup, RA
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (03) : 1160 - 1168
  • [7] Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy
    Casazza, JP
    Betts, MR
    Picker, LJ
    Koup, RA
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (14) : 6508 - 6516
  • [8] INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS
    CLERICI, M
    STOCKS, NI
    ZAJAC, RA
    BOSWELL, RN
    BERNSTEIN, DC
    MANN, DL
    SHEARER, GM
    BERZOFSKY, JA
    [J]. NATURE, 1989, 339 (6223) : 383 - 385
  • [9] Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers
    Day, CL
    Seth, NP
    Lucas, M
    Appel, H
    Gauthier, L
    Lauer, GM
    Robbins, GK
    Szczepiorkowski, ZM
    Casson, DR
    Chung, RT
    Bell, S
    Harcourt, G
    Walker, BD
    Klenerman, P
    Wucherpfennig, KW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) : 831 - 842
  • [10] Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1
    Deeks, SG
    Martin, JN
    Sinclair, E
    Harris, J
    Neilands, TB
    Maecker, HT
    Hagos, E
    Wrin, T
    Petropoulos, CJ
    Bredt, B
    Mccune, JM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02) : 312 - 321